Jinxia Zhu Selected Research

Jinxia Zhu Research Topics

Disease

4	Parkinson Disease (Parkinson's Disease) 01/2020 - 07/2014
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 10/2024 - 09/2023
3	Reperfusion Injury 01/2023 - 01/2020
2	Liver Cirrhosis (Hepatic Cirrhosis) 02/2024 - 01/2022
2	Hypoxia (Hypoxemia) 02/2024 - 01/2022
2	Pathologic Constriction (Stenosis) 04/2023 - 01/2021
2	Inflammation (Inflammations) 04/2023 - 01/2012
2	Anemia 01/2023 - 08/2021
2	Insulinoma 12/2022 - 11/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 02/2024
1	Liver Diseases (Liver Disease) 02/2024
1	Autoimmune Hepatitis 08/2023
1	Interstitial Lung Diseases (Interstitial Lung Disease) 04/2023
1	Iron Overload 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Atrophy 06/2022
1	Cognitive Dysfunction 06/2022
1	Fibrosis (Cirrhosis) 01/2022
1	Neoplasms (Cancer) 01/2022
1	REM Sleep Behavior Disorder 10/2021
1	Gastroesophageal Reflux (GERD) 08/2021
1	Laryngopharyngeal Reflux 08/2021
1	Intracranial Aneurysm (Cerebral Aneurysm) 01/2021
1	Ischemia 01/2020
1	Constipation 08/2015
1	Gastroparesis 07/2014
1	Diarrhea 01/2012
1	Adenoma (Adenomas) 01/2012
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2012
1	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 12/2008

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 10/2024 - 01/2020
3	Oxidopamine (6 Hydroxydopamine)IBA 01/2019 - 07/2014
2	Carbon Tetrachloride (Tetrachloromethane)IBA 02/2024 - 01/2022
2	Hematoxylin (Haematoxylon)IBA 02/2024 - 01/2022
2	Eosine Yellowish-(YS) (Eosin)IBA 02/2024 - 01/2022
2	CreatinineIBA 02/2024 - 01/2022
2	Phenobarbital (Luminal)FDA Link 04/2023 - 01/2012
2	IronIBA 01/2023 - 10/2021
1	AlloxanIBA 02/2024
1	Lipocalin-2IBA 02/2024
1	Oxygen (Dioxygen)IBA 02/2024
1	5,7- dihydroxy- 6- methoxy- 2- phenylchromen- 4- oneIBA 08/2023
1	EnzymesIBA 04/2023
1	Indicators and Reagents (Reagents)IBA 04/2023
1	CalciumIBA 01/2023
1	Phosphorus (Red Phosphorus)IBA 01/2023
1	7- chloro- 8- hydroxy- 1- (3'- iodophenyl)- 3- methyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepine (TISCH)IBA 12/2022
1	BilirubinIBA 01/2022
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	NitrogenIBA 01/2022
1	Urea (Carbamide)FDA LinkGeneric 01/2022
1	BismuthIBA 01/2022
1	Exenatide (Byetta)FDA Link 11/2021
1	Glucagon-Like Peptide-1 ReceptorIBA 11/2021
1	Pepsin A (Pepsin)IBA 08/2021
1	Alprostadil (Muse)FDA LinkGeneric 01/2020
1	salicylhydroxamic acid (SHAM)IBA 01/2020
1	ProstaglandinsIBA 01/2020
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 08/2015
1	Dopamine (Intropin)FDA LinkGeneric 08/2015
1	Serotonin (5 Hydroxytryptamine)IBA 08/2015
1	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2014
1	Messenger RNA (mRNA)IBA 01/2012
1	CytokinesIBA 01/2012
1	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2012
1	Sodium-Hydrogen Exchanger 3IBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 01/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2012
1	Epithelial Sodium ChannelsIBA 01/2012
1	GTP-Binding Proteins (G-Protein)IBA 12/2008

Therapy/Procedure

3	Renal Dialysis (Hemodialysis) 01/2023 - 08/2021
2	Aftercare (After-Treatment) 02/2024 - 09/2023
2	Warm Ischemia 12/2020 - 01/2020
1	Subcutaneous Injections 02/2024
1	Kidney Transplantation 01/2023
1	Hepatectomy 01/2022
1	Ligation 01/2022
1	Stents 01/2021